Research & Scientists | Surgical Sciences | People | ID7404


Name: Olívia Pontes

Office: I1.02

School Phone: +351 604 837

Email: id7404@alunos.uminho.pt






Renal cell carcinoma (RCC) is the most common type of cancer among the urological system. Until recently, treatment was limited since this type of cancer is resistant to chemo- and radiotherapy. Due to low response rates and identification of new targets linked to RCC initiation and progression, other pathways were investigated leading to targeted therapies to treat RCC. Despite the improvement of survival rates, activation of other vias and additional genetic and epigenetic modifications may cause cancer cell resistance to targeted therapies. Thus, improving therapeutic selectivity and efficacy and overcoming drug resistance are the major goals of my current work.

Copyright © 2012-2016 ICVS. All rights reserved.